Vicki Moore, PhD

Contributing Writer https://www.hematologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Bleeding Disorders

Circulating Extracellular Vesicles and Factor VIIa Treatment in Patients With Hemophilia

Vicki Moore, PhD

July 1, 2022

Researchers characterized the abundance and impacts of extracellular vesicles associated with recombinant factor VIIa treatment in patients with hemophilia.

Several novel treatment agents for myeloproliferative neoplasms are currently being studied in phase 1 or phase 2 trials.

Leukemia

Bax/Bcl-2 Expression in Pediatric Acute Lymphoblastic Leukemia

Vicki Moore, PhD

June 30, 2022

Researchers sought to determine the impact of Bax and Bcl-2 expression in pediatric patients with acute lymphoblastic leukemia after completing induction chemotherapy.

Lymphoma

Response to Axicabtagene Ciloleucel Superior to Standard Care in R/R Large B-Cell Lymphoma

Vicki Moore, PhD

June 28, 2022

Axi-cel improved event-free survival vs standard care in older patients with relapsed/refractory large B-cell lymphoma.

Analysis from phase II ENDEAVOR trial showed Kyprolis and dexamethasone superior to Velcade and dexa

Myeloma

Factors Related to Adherence to Oral Multiple Myeloma Therapy

Vicki Moore, PhD

June 22, 2022

Researchers sought to identify socioeconomic and demographic factors related to adherence to oral therapies in patients with multiple myeloma.

This fact sheet provides an overview of the updated ESMO clinical practice guideline for hereditary GI cancers.

General Hematology

Patient-Reported Outcomes and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation

Vicki Moore, PhD

June 22, 2022

Researchers sought to find whether there was a relationship between patient-reported outcomes and overall survival after hematopoietic stem cell transplantation.

General Hematology

Momelotinib Bests Danazol in Symptomatic, Anemic Myelofibrosis

Vicki Moore, PhD

June 21, 2022

Momelotinib proved superior to danazol in patients with symptomatic, anemic myelofibrosis in a phase 3 study.

Myeloma

Adaptation to Bortezomib Treatment in Multiple Myeloma Cells

Vicki Moore, PhD

June 17, 2022

Researchers sought to characterize features of multiple myeloma cells that may be involved in treatment resistance to bortezomib.

General Hematology

Varicella-Zoster Vaccination After Allogeneic Stem Cell Transplantation

Vicki Moore, PhD

June 16, 2022

Researchers sought to determine whether varicella-zoster virus vaccination with a recombinant vaccine would show results in patients who underwent HSCT.

Thalassemias

Lipid Profiles in Beta-Thalassemia With IVS Mutations and Hydroxyurea Therapy

Vicki Moore, PhD

June 10, 2022

Researchers sought to identify lipid profiles of red blood cell membranes in patients with beta-thalassemia, in the context of IVS mutations and hydroxyurea treatment.